No insider purchase over the last 90 days. The latest, by GILLIS STEVEN, was filed 05 Apr 2018.
This page follows insider dealings at Pulmatrix, Inc. as filed with SEC (Form 4). Pulmatrix, Inc. has had no insider filing for more than a year; the last one goes back to 5 April 2018.
Looking back to 2017, when coverage begins, insiders filed 9 purchases and no sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
11 of 11 declarations
Pulmatrix, Inc. is a company focused on developing respiratory therapies based on advanced technologies. It is listed on the XNAS market.